Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-6,968
Closed -$201K 88
2023
Q4
$201K Sell
6,968
-649
-9% -$19.6K 0.08% 84
2023
Q3
$253K Buy
+7,617
New +$269K 0.1% 68
2020
Q1
Sell
-12,882
Closed -$479K 59
2019
Q4
$479K Buy
+12,882
New +$459K 0.42% 43

Other funds holding PFE

S.E.E.D. Planning Group's PFE Position: Q1 2024 in Review

S.E.E.D. Planning Group sold out of Pfizer (PFE) in Q1 2024, closing a stake of 6,968 shares — an estimated $201K sold.

S.E.E.D. Planning Group first reported a position in PFE in Q4 2019 and held it in 3 quarters. The position peaked at $479K in Q4 2019. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

  • S.E.E.D. Planning Group reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
  • S.E.E.D. Planning Group sold 6,968 Pfizer shares in Q1 2024, an estimated $201K.
  • S.E.E.D. Planning Group first reported a position in Pfizer in Q4 2019 and held it in 3 quarters.
  • S.E.E.D. Planning Group's Pfizer position peaked at $479K in Q4 2019.
  • 2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on S.E.E.D. Planning Group's 13F filing for Q1 2024, filed 16 Apr 2024.